Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.67 USD
−53.78 M USD
31.54 M USD
37.55 M
About Silence Therapeutics, Plc.
Sector
CEO
Craig Allen Tooman
Website
Headquarters
London
Founded
1994
FIGI
BBG00WVTHPN2
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.